Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Weidinger

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|December 19, 2019
Metabolic Control of Epigenetics and Its Role in CD8<sup>+</sup> T Cell Differentiation and FunctionCansu Yerinde, Britta Siegmund, Rainer Glauben, et al.
Frontiers in Immunology|August 15, 2017
Anti-Adhesion Therapies in Inflammatory Bowel Disease-Molecular and Clinical AspectsSebastian Zundler, Emily Becker, Carl Weidinger, et al.
Mucosal Immunology|February 20, 2021
COVID-19-from mucosal immunology to IBD patientsCarl Weidinger, Ahmed Nabil Hegazy, Rainer Glauben, et al.
Innovative Surgical Sciences|October 16, 2023
Postoperative intussusception: a rare but critical complication in adult patients with Crohn's disease - case report and literature reviewSophie M Eschlböck, Benjamin Weixler, Carl Weidinger, et al.
Endocrine-Related Cancer|September 9, 2008
Forkhead box-O transcription factor: critical conductors of cancer's fateCarl Weidinger, Kerstin Krause, Antje Klagge, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfideCarl Weidinger, Kerstin Krause, Kathrin Mueller, et al.
Journal of Clinical Immunology|March 2, 2022
Early Onset of TNFα-Driven Arthritis, Auto-inflammation, and Progressive Loss of Vision in a Patient with ALPK1 MutationJulia Hecker, Marilena Letizia, Britt-Sabina Loescher, et al.
Frontiers in Immunology|October 30, 2018
Adipokines and Their Role in Intestinal InflammationCarl Weidinger, Jörn F Ziegler, Marilena Letizia, et al.
Frontiers in Medicine|December 27, 2021
Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic TargetsCarl Weidinger, Susanne M Krug, Caroline Voskens, et al.
Endocrine-Related Cancer|June 30, 2011
The role of FOXO3 in DNA damage response in thyrocytesAntje Klagge, Carl Weidinger, Kerstin Krause, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|December 19, 2019
Metabolic Control of Epigenetics and Its Role in CD8<sup>+</sup> T Cell Differentiation and FunctionCansu Yerinde, Britta Siegmund, Rainer Glauben, et al.
Frontiers in Immunology|August 15, 2017
Anti-Adhesion Therapies in Inflammatory Bowel Disease-Molecular and Clinical AspectsSebastian Zundler, Emily Becker, Carl Weidinger, et al.
Mucosal Immunology|February 20, 2021
COVID-19-from mucosal immunology to IBD patientsCarl Weidinger, Ahmed Nabil Hegazy, Rainer Glauben, et al.
Innovative Surgical Sciences|October 16, 2023
Postoperative intussusception: a rare but critical complication in adult patients with Crohn's disease - case report and literature reviewSophie M Eschlböck, Benjamin Weixler, Carl Weidinger, et al.
Endocrine-Related Cancer|September 9, 2008
Forkhead box-O transcription factor: critical conductors of cancer's fateCarl Weidinger, Kerstin Krause, Antje Klagge, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfideCarl Weidinger, Kerstin Krause, Kathrin Mueller, et al.
Journal of Clinical Immunology|March 2, 2022
Early Onset of TNFα-Driven Arthritis, Auto-inflammation, and Progressive Loss of Vision in a Patient with ALPK1 MutationJulia Hecker, Marilena Letizia, Britt-Sabina Loescher, et al.
Frontiers in Immunology|October 30, 2018
Adipokines and Their Role in Intestinal InflammationCarl Weidinger, Jörn F Ziegler, Marilena Letizia, et al.
Frontiers in Medicine|December 27, 2021
Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic TargetsCarl Weidinger, Susanne M Krug, Caroline Voskens, et al.
Endocrine-Related Cancer|June 30, 2011
The role of FOXO3 in DNA damage response in thyrocytesAntje Klagge, Carl Weidinger, Kerstin Krause, et al.
Pageof 6